KYNTRA BIO, INC. (KYNB) Gross margin 2019–2025
KYNTRA BIO, INC. (KYNB) gross margin by fiscal year — reported gross profit divided by reported revenue.
91.4%FY2025 · since FY2019: 99.6% → 91.4%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 91.4% | +43.9 pp |
| FY2024 | 47.5% | -44.1 pp |
| FY2023 | 91.5% | +5.9 pp |
| FY2022 | 85.6% | -8.9 pp |
| FY2021 | 94.5% | -0.4 pp |
| FY2020 | 95.0% | -4.6 pp |
| FY2019 | 99.6% | — |
Gross margin = reported gross profit ÷ reported revenue for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More KYNB financial trends
KYNB RevenueKYNB Net incomeKYNB Net marginKYNB Gross profitKYNB Operating incomeKYNB Operating marginKYNB Operating cash flowKYNB Free cash flowKYNB Capital expendituresKYNB Return on equityKYNB Stock buybacksKYNB Dividends paidKYNB Total assetsKYNB Total liabilitiesKYNB Shareholders’ equityKYNB overview →